HFS
APGE icon

Hughes Financial Services’s Apogee Therapeutics APGE Stock Holding History

Hughes Financial Services’s Portfolio APGE Stock Details APGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.73K Buy
13
+1
+8% +$90 ﹤0.01% 788
2026
Q1 		$1.01K Sell
12
-6
-33% -$436 ﹤0.01% 761
2025
Q4 		$1.36K Buy
18
+1
+6% +$63 ﹤0.01% 643
2025
Q3 		$965 Hold
17
– – ﹤0.01% 731
2025
Q2 		$617 Buy
+17
New +$647 ﹤0.01% 862

Other funds holding APGE

Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CCM
Chicago Capital Management Chicago, Illinois $112M AUM 76.54% 1-Year Est. Return
CIEC
Crédit Industriel et Commercial Paris France, France $1.55B AUM 42.08% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
TH
Transmarket Holdings Chicago, Illinois $136M AUM
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
AA
AlphaCentric Advisors San Juan, Puerto Rico $118M AUM
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
SOAM
SBI Okasan Asset Management Tokyo, Japan $3.04B AUM
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

Hughes Financial Services's APGE Position: Q2 2026 in Review

Hughes Financial Services increased its Apogee Therapeutics (APGE) stake by 8.3% in Q2 2026, buying an estimated $90 and bringing the position to 13 shares worth $1.73K. The position accounts for ﹤0.01% of the portfolio, ranked #788.

Hughes Financial Services first reported a position in APGE in Q2 2025 and has held it in 5 quarters since. 24 funds tracked by Wall St. Rank hold APGE as of Q2 2026.

  • Hughes Financial Services held 13 shares of Apogee Therapeutics worth $1.73K as of Q2 2026.
  • Hughes Financial Services bought 1 Apogee Therapeutics share in Q2 2026, an estimated $90.
  • Apogee Therapeutics made up ﹤0.01% of Hughes Financial Services's portfolio in Q2 2026, its #788 holding.
  • Hughes Financial Services first reported a position in Apogee Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • 24 funds tracked by Wall St. Rank held Apogee Therapeutics as of Q2 2026.

Based on Hughes Financial Services's 13F filing for Q2 2026, filed 20 Jul 2026.